Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursochol in Functional Dyspepsia
NCT03004118Phase 4Active, not recruiting
- Sponsor
- UZ Leuven
- Start
- Jan 2017
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ursodeoxycholic acid in functional dyspepsia (FD), sponsored by UZ Leuven. Started Jan 2017; status: active, not recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03004118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004118.